Key statistics
As of last trade, Poseida Therapeutics Inc (2RZ:DEU) traded at 2.36, 39.64% above the 52 week low of 1.69 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.32 |
---|---|
High | 2.47 |
Low | 2.28 |
Bid | 2.40 |
Offer | 2.44 |
Previous close | 2.34 |
Average volume | 1.22k |
---|---|
Shares outstanding | 97.12m |
Free float | 70.18m |
P/E (TTM) | -- |
Market cap | 258.34m USD |
EPS (TTM) | -1.19 USD |
Data delayed at least 15 minutes, as of Oct 07 2024.
More ▼
Press releases
- Poseida Therapeutics Named to Newsweek's List of the Top 200 America's Most Loved Workplaces for 2024
- Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients
- Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-ALLO1 to Treat Relapsed/Refractory Multiple Myeloma
- Poseida Therapeutics to Present New Clinical Data from Phase 1 Study of Allogeneic CAR-T P-BCMA-ALLO1 in Patients with Relapsed/Refractory Multiple Myeloma at 21st International Myeloma Society Annual Meeting
- Poseida Therapeutics to Present at Upcoming Investor Conferences
- Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2024
More ▼